Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication April 5, 2007
- Accepted for publication June 8, 2007
- Published online September 4, 2007.
Article Versions
- previous version (August 17, 2007 - 08:46).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2007 by Society of Nuclear Medicine
Author Information
- Roslyn J. Francis 1 ,
- Michael J. Byrne 2 ,
- Agatha A. van der Schaaf 1 ,
- Jan A. Boucek 1 ,
- Anna K. Nowak 2 , 3 ,
- Michael Phillips 4 ,
- Richard Price 5 ,
- Andrew P. Patrikeos 1 ,
- A. William Musk 6 and
- Michael J. Millward 2 , 3
- 1Department of Nuclear Medicine/WA PET Centre, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia; 2Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia; 3School of Medicine and Pharmacology, Faculty of Medicine and Dentistry and Health Science, University of Western Australia, Western Australia, Australia; 4Cancer Council Clinical Trials Biostatistics Department, WA Institute for Medical Research, Sir Charles Gairdner Hospital, University of Western Australia, Nedlands, Western Australia, Australia; 5Department of Radiology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia; and 6Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia
- For correspondence or reprints contact: Roslyn Francis, MBBS, PhD, Department of Nuclear Medicine/WA PET Centre, Sir Charles Gairdner Hospital, Verdun St., Nedlands, Western Australia, 6009, Australia. E-mail: Ros.Francis{at}health.wa.gov.au
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
Related Articles
Cited By...
- PET/CT Imaging in Lung Cancer
- Volumetric PET Response Assessment Outperforms Conventional Criteria in Patients Receiving High-Dose Pembrolizumab for Malignant Mesothelioma
- 18F-FDG PET Assessment of Malignant Pleural Mesothelioma: Total Lesion Volume and Total Lesion Glycolysis--The Central Role of Volume
- Early PET/CT Scan Is More Effective Than RECIST in Predicting Outcome of Patients with Liver Metastases from Colorectal Cancer Treated with Preoperative Chemotherapy Plus Bevacizumab
- Prognostic Ability of 18F-FDG PET/CT in the Assessment of Colorectal Liver Metastases
- Serum Soluble Mesothelin Concentrations in Malignant Pleural Mesothelioma: Relationship to Tumor Volume, Clinical Stage and Changes in Tumor Burden
- Volume-of-Interest Assessment of Oncologic Response Using 18F-FDG PET/CT: A Phantom Study
- Reproducibility of 18F-FDG and 3'-Deoxy-3'-18F-Fluorothymidine PET Tumor Volume Measurements
- Investigation of a unilateral pleural effusion in adults: British Thoracic Society pleural disease guideline 2010
- A Novel Prognostic Model for Malignant Mesothelioma Incorporating Quantitative FDG-PET Imaging with Clinical Parameters
- Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma
- From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
- Role of 18F-FDG PET in Assessment of Response in Non-Small Cell Lung Cancer
- Tumor Volume Assessment by 18F-FDG PET/CT in Patients with Oral Cavity Cancer with Dental Artifacts on CT or MR Images